Harding, Damian J <br/><br/>
Successful Use of Dasatinib After Liver Transplantation for Imatinib-Induced Fulminant Liver Failure in Chronic Myeloid Leukemia.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Apr 2016 
 - e97-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2013.50.1320  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--administration & dosage<br/>Dasatinib--administration & dosage<br/>Female<br/>Fusion Proteins, bcr-abl--antagonists & inhibitors<br/>Humans<br/>Imatinib Mesylate--administration & dosage<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Liver Failure, Acute--chemically induced<br/>Liver Transplantation<br/>Protein Kinase Inhibitors--administration & dosage<br/>Treatment Outcome